McKesson Corporation
Precio: 787.19Empresa y modelo de negocio
McKesson Corporation is a leading healthcare services and information technology company. It primarily operates in the distribution of pharmaceuticals and provides healthcare management solutions. Major business segments include pharmaceutical distribution, medical-surgical distribution, and healthcare technology. The company's main revenue sources are from the sale of prescription drugs, medical supplies, and related services to healthcare providers, pharmacies, and hospitals.
Perfil de inversión
The investment profile of McKesson Corporation is more aligned with value investors, given its stable revenue growth and modest dividend yield. The stock may appeal to those seeking a balanced approach, as it offers potential for capital appreciation alongside income generation. However, the higher risk factors suggest caution for investors.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 38.64 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- -9.3% ↓
- Sorpresa EPS
- 1.9% en línea
- Volatilidad 20d
- 1.4% estable
- Rendimiento de dividendos
- 0.4% bajo última fecha ex-div.: 2026-06-01
Seguir en portafolio
Gráfico de precio
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-09 02:45 | Comprar | Vender | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-05 02:42 | Mantener | Comprar | Mixed performance; cautious outlook amid market pressures. |
| 2026-06-01 02:44 | Vender | Mantener | Weak momentum and high risk overshadow potential upside. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-05-08 14:52 | UBS | Objetivo aumentado | 1000 → 1050 | 744.46 |
| 2026-05-08 12:53 | Deutsche Bank | Objetivo reducido | 973 → 875 | 763.9 |
| 2026-03-05 15:28 | Raymond James | Actualizar | — → 970 | 930.31 |
Nada todavía